NFX vs. PYC, OVB, FAB, APTA, EVG, OCTP, IXI, VAL, BSFA, and ROQ
Should you be buying Nuformix stock or one of its competitors? The main competitors of Nuformix include Physiomics (PYC), Ovoca Bio (OVB), Fusion Antibodies (FAB), Aptamer Group (APTA), Evgen Pharma (EVG), Oxford Cannabinoid Technologies (OCTP), IXICO (IXI), ValiRx (VAL), BSF Enterprise (BSFA), and Roquefort Therapeutics (ROQ). These companies are all part of the "biotechnology" industry.
Physiomics (LON:PYC) and Nuformix (LON:NFX) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their community ranking, institutional ownership, media sentiment, dividends, profitability, earnings, analyst recommendations, risk and valuation.
Nuformix has a net margin of 0.00% compared to Nuformix's net margin of -70.32%. Physiomics' return on equity of -27.25% beat Nuformix's return on equity.
In the previous week, Nuformix's average media sentiment score of 0.00 equaled Physiomics'average media sentiment score.
Physiomics has higher revenue and earnings than Nuformix.
Physiomics received 12 more outperform votes than Nuformix when rated by MarketBeat users. However, 66.67% of users gave Nuformix an outperform vote while only 55.56% of users gave Physiomics an outperform vote.
Physiomics has a beta of 1.78, suggesting that its stock price is 78% more volatile than the S&P 500. Comparatively, Nuformix has a beta of 0.29, suggesting that its stock price is 71% less volatile than the S&P 500.
0.1% of Physiomics shares are held by institutional investors. Comparatively, 0.2% of Nuformix shares are held by institutional investors. 6.3% of Physiomics shares are held by company insiders. Comparatively, 15.0% of Nuformix shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
Summary
Nuformix beats Physiomics on 8 of the 11 factors compared between the two stocks.
Get Nuformix News Delivered to You Automatically
Sign up to receive the latest news and ratings for NFX and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Nuformix Competitors List
Related Companies and Tools
